8 unchanged sentences
filed a complaint in the U.S.
−Removed: District Court for the Northern District of Illinois against the Company, one of its wholly-owned subsidiaries and an individual scientist, alleging misappropriation of trade secrets concerning the Company’s BTK degrader program, including the lead compound, BGB-16673.
+Added: District Court for the Northern District of Illinois against the Company, one of its wholly-owned subsidiaries and an individual scientist, alleging misappropriation of trade secrets concerning the Company’s BTK degrader program, including the lead compound, BGB-16673 (tacabrutideg).
The complaint seeks an unspecified amount of monetary damages, declaratory judgment, restitution and other equitable remedies.
−Removed: The Company is vigorously defending against the claims and filed a motion to dismiss the complaint in its entirety on December 19, 2024.
+Added: The Company filed a motion to dismiss the complaint in its entirety on December 19, 2024.
+Added: On May 12, 2026, the Court denied the Company’s motion to dismiss.
+Added: The litigation remains ongoing, no trial date has been scheduled, and the Company is vigorously defending against the claims.
ANDA Litigation
5 unchanged sentences
According to the notice, Zydus has not challenged BRUKINSA’s composition of matter patent, which remains intact and protects BRUKINSA ® from generic competition until its expiration in 2034.
−Removed: BeOne’s complaint alleges that by filing the ANDA, Zydus infringes certain of BRUKISNA’s Orange Book patents and seeks a permanent injunction to prevent Zydus from commercializing a generic version of BRUKINSA ® tablets until the expiration of the asserted patents.
+Added: BeOne’s complaint alleges that by filing the ANDA, Zydus infringes certain of BRUKINSA’s Orange Book patents and seeks a permanent injunction to prevent Zydus from commercializing a generic version of BRUKINSA ® tablets until the expiration of the asserted patents.
ANDA litigation is common in the U.S.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.